S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   271.71 (-0.28%)
AAPL   459.22 (-0.18%)
MSFT   208.40 (-0.14%)
FB   260.48 (-0.31%)
GOOGL   1,501.52 (-1.00%)
AMZN   3,147.00 (-0.44%)
NVDA   462.43 (+1.03%)
CGC   17.19 (-0.75%)
BABA   253.80 (+0.03%)
TSLA   1,649.85 (+1.78%)
GE   6.65 (+0.76%)
MU   45.60 (-1.17%)
AMD   81.27 (-0.70%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.38 (+0.29%)
NFLX   482.55 (+0.25%)
DIS   130.53 (-0.33%)
BAC   26.42 (+0.27%)
BA   177.73 (+1.72%)
S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   271.71 (-0.28%)
AAPL   459.22 (-0.18%)
MSFT   208.40 (-0.14%)
FB   260.48 (-0.31%)
GOOGL   1,501.52 (-1.00%)
AMZN   3,147.00 (-0.44%)
NVDA   462.43 (+1.03%)
CGC   17.19 (-0.75%)
BABA   253.80 (+0.03%)
TSLA   1,649.85 (+1.78%)
GE   6.65 (+0.76%)
MU   45.60 (-1.17%)
AMD   81.27 (-0.70%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.38 (+0.29%)
NFLX   482.55 (+0.25%)
DIS   130.53 (-0.33%)
BAC   26.42 (+0.27%)
BA   177.73 (+1.72%)
S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   271.71 (-0.28%)
AAPL   459.22 (-0.18%)
MSFT   208.40 (-0.14%)
FB   260.48 (-0.31%)
GOOGL   1,501.52 (-1.00%)
AMZN   3,147.00 (-0.44%)
NVDA   462.43 (+1.03%)
CGC   17.19 (-0.75%)
BABA   253.80 (+0.03%)
TSLA   1,649.85 (+1.78%)
GE   6.65 (+0.76%)
MU   45.60 (-1.17%)
AMD   81.27 (-0.70%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.38 (+0.29%)
NFLX   482.55 (+0.25%)
DIS   130.53 (-0.33%)
BAC   26.42 (+0.27%)
BA   177.73 (+1.72%)
S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   271.71 (-0.28%)
AAPL   459.22 (-0.18%)
MSFT   208.40 (-0.14%)
FB   260.48 (-0.31%)
GOOGL   1,501.52 (-1.00%)
AMZN   3,147.00 (-0.44%)
NVDA   462.43 (+1.03%)
CGC   17.19 (-0.75%)
BABA   253.80 (+0.03%)
TSLA   1,649.85 (+1.78%)
GE   6.65 (+0.76%)
MU   45.60 (-1.17%)
AMD   81.27 (-0.70%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.38 (+0.29%)
NFLX   482.55 (+0.25%)
DIS   130.53 (-0.33%)
BAC   26.42 (+0.27%)
BA   177.73 (+1.72%)
Log in

NASDAQ:PTCTPTC Therapeutics Price Target & Analyst Ratings

$48.92
-0.57 (-1.15 %)
(As of 08/14/2020 04:00 PM ET)
Add
Compare
Today's Range
$48.75
Now: $48.92
$49.99
50-Day Range
$46.33
MA: $50.98
$57.07
52-Week Range
$30.79
Now: $48.92
$59.89
Volume8,128 shs
Average Volume868,270 shs
Market Capitalization$3.31 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.32

Analyst Ratings

PTC Therapeutics (NASDAQ:PTCT) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
9 Wall Street analysts have issued ratings and price targets for PTC Therapeutics in the last 12 months. Their average twelve-month price target is $60.50, suggesting that the stock has a possible upside of 23.67%. The high price target for PTCT is $86.00 and the low price target for PTCT is $45.00. There are currently 4 hold ratings and 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.562.632.632.80
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $60.50$62.83$62.83$59.13
Price Target Upside: 23.67% upside32.73% upside32.73% upside7.63% upside

PTC Therapeutics (NASDAQ:PTCT) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

PTC Therapeutics (NASDAQ:PTCT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/11/2020Cantor FitzgeraldLower Price TargetOverweight$85.00 ➝ $75.00Low
8/10/2020Bank of AmericaLower Price TargetBuy$60.00 ➝ $58.00Medium
8/10/2020Credit Suisse GroupLower Price TargetNeutral$53.00 ➝ $52.00Low
7/20/2020CowenReiterated RatingHold$50.00High
7/20/2020SunTrust BanksBoost Price TargetBuy$75.00 ➝ $86.00High
4/28/2020William BlairReiterated RatingBuyLow
4/9/2020CitigroupUpgradeNeutral ➝ Buy$71.00 ➝ $67.00High
4/8/2020Royal Bank of CanadaReiterated RatingHold$45.00High
3/4/2020BarclaysReiterated RatingHold$51.00High
4/11/2019Sanford C. BernsteinInitiated CoverageOutperform$48.00Low
9/28/2018JPMorgan Chase & Co.Boost Price TargetPositive ➝ Neutral$51.00Low
(Data available from 8/14/2018 forward)
This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.